Highest-materiality recent filing
Darling Q1 net income $134.3M; Combined Adj. EBITDA $406.8M; core Q2 guidance $260-275M
Net income $134.3M ($0.83 diluted EPS) vs net loss $(26.2M) ($(0.16)) in Q1 2025.
Darling Q4 net income $56.9M ($0.35 EPS) down 44% YoY; sales $1.7B; guides Q1 core EBITDA $240-250M
Net income $56.9M ($0.35 diluted EPS) vs $101.9M ($0.63) in Q4 2024; total net sales $1.7B vs $1.42B.
Darling Ingredients reports DGD JV Q4 net income $55M; full-year loss $68M on weaker margins
DGD Q4 2025 net income $55M, sold 285.3M gallons; Darling's share of DGD Adj. EBITDA $58M ($0.41/gal).
Darling Ingredients and Tessenderlo form collagen JV; Darling 85% stake, ~$1.5B revenue
Darling will hold 85% equity interest; Tessenderlo 15% in new company NewCo Collagen LLC.
Darling Q3 net income $19.4M ($0.12 EPS), sales up 10% to $1.6B; DGD EBITDA negative
Net income $19.4M ($0.12 diluted EPS) vs $16.9M ($0.11) YoY; total net sales $1.6B (+10% from $1.4B).
Darling Ingredients COO Jansen departs; gets $500K advisory fee through Mar 2026
Matt Jansen left as COO North America effective Sept 26, 2025; termination was without cause.
Darling Ingredients COO North America Matt Jansen departs effective Sept 26, 2025
Matt Jansen, COO – North America, departed Darling Ingredients effective September 26, 2025.
Darling Q2 net income falls to $0.08 EPS; guides FY25 Combined Adj. EBITDA to $1.05-1.10B
Net income of $12.7M ($0.08 diluted EPS) vs $78.9M ($0.49) a year ago, hurt by lower DGD earnings.
Darling Ingredients issues €750M 4.5% senior notes due 2032, refinances credit facilities
Issued €750M aggregate principal of 4.5% senior notes due July 15, 2032 via subsidiary Darling Global Finance B.V.
Darling to hold 85% ownership in new company Nextida; Tessenderlo 15%; no cash exchanged.
Darling Ingredients Q1 net loss $26.2M; DGD drags Combined Adj EBITDA to $195.8M
Net loss of $26.2M ($0.16 diluted EPS) vs net income $81.2M ($0.50) YoY on lower DGD earnings.
Darling Q4 net income $0.63/shr; FY Combined Adj. EBITDA $1.08B; guides FY25 $1.25-$1.30B
Q4 net income $101.9M ($0.63 diluted) vs $84.5M ($0.52) YoY; net sales $1.4B, -12% YoY.
Darling Ingredients reports DGD Q4 operating income ~$170M; core business strongest quarter of 2024
DGD Q4 operating income ~$170M (JV partner); stand-alone DGD incurred $118M LCM charge.
Darling Ingredients CFO Brad Phillips to retire; Robert Day named successor effective Feb. 2025
Brad Phillips retires June 15, 2025 after 36 years; will assist transition through retirement.
Darling Q3 net income $16.9M vs $125M YoY; revenue falls to $1.42B; EBITDA guidance reaffirmed
Net income $16.9M ($0.11 diluted EPS) vs $125.0M ($0.77) in Q3 2023, driven by lower fat prices and weaker DGD earnings.
Darling Q2 net income $78.9M ($0.49), down 69% YoY; combined adj. EBITDA $273.6M
Net income $78.9M ($0.49 diluted) vs $252.4M ($1.55) in Q2 2023; net sales $1.5B vs $1.8B, down 17%.
Q1 net income falls to $81M ($0.50/sh) on weak fat prices and lower DGD earnings
Net sales $1.4B, down 22% YoY from $1.8B; net income $81.2M vs $185.8M.
Darling Q4 EPS $0.52 vs $0.96 YoY; FY combined EBITDA $1.61B up 4.6%
Q4 net income $84.5M ($0.52 diluted EPS) vs $156.6M ($0.96) in Q4 2022; revenue $1.61B down 9% YoY.
Darling Ingredients completes acquisition of Polish rendering company Miropasz Group for €110M
Completed acquisition of Miropasz Group for €110 million purchase price (plus/minus closing costs).
Darling Q3 net income falls 34% to $125M; combined adj. EBITDA $334.3M
GAAP diluted EPS $0.77 vs $1.17 a year ago; net sales $1.6B, down 7% YoY.
Darling Ingredients cuts FY2023 EBITDA guidance to $1.6-$1.7B; cites DGD disruptions & hedge loss
DGD joint venture volumes down due to 37-day outage from turnaround and minor fire at DGD 2 in St. Charles, La.
Darling Ingredients Q2 net income $252.4M, EPS $1.55, record combined EBITDA $508.3M
Net sales $1.8B up from $1.7B YoY; GAAP EPS $1.55 vs $1.23.
Darling Ingredients Q1 net sales $1.8B, adjusted EBITDA $418.4M, reaffirms FY2023 guidance
Net sales $1.79B (+31% YoY); net income $185.8M ($1.14 diluted EPS) vs $188.1M prior year.
Darling Ingredients completes $1.2B acquisition of Gelnex, gelatin and collagen producer
Acquisition closed on March 31, 2023; purchase price ~$1.2B in cash plus adjustments.
FY2022 net income $737.7M ($4.49 diluted EPS) vs $650.9M ($3.90) in 2021; revenue $6.5B vs $4.7B.
Darling Q3 2022 EPS $1.17, net sales $1.7B; EBITDA $394.7M; reaffirms FY22 guidance
Net income $191M ($1.17 diluted EPS) vs $146.8M ($0.88) in Q3 2021; net sales $1.7B (+47% YoY).
Darling Ingredients to acquire Polish rendering company Miropasz Group for €110M
Acquisition price of approximately €110 million, subject to post-closing adjustments.
Darling Ingredients to acquire Brazilian collagen producer Gelnex for $1.2B cash
Purchase price ~$1.2B USD in cash; expected close Q1 2023 subject to regulatory approvals.
Darling Ingredients adds $800M in delayed draw term facilities via credit agreement amendment
Added Term A-3 Facility up to $300M and Term A-4 Facility up to $500M, total $800M.
On February 20, 2025, the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) elected Soren Schroder to the Board and appointed him as a member of the Board’s Audit Committee and Compensation Committee, effective immediately.
On September 13, 2024, the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) elected Randy L. Hill to the Board and appointed him as a member of the Board’s Audit Committee and Sustainability Committee, effective immediately.
On July 24, 2024, Michael E. Rescoe, a member of the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) since 2017, notified the Company and the Board that he was retiring from the Board effective July 24, 2024.
John Bullock, the Executive Vice President and Chief Strategy Officer of Darling Ingredients Inc. (the “Company”), and a named executive officer in the Company’s Proxy Statement dated March 23, 2023, informed the Company of his intention to retire effective February 15, 2024.
On May 10, 2023, Rick A. Elrod, the Executive Vice President, U.S. Rendering Operations of Darling Ingredients Inc. (the “Company”), and a named executive officer in the Company’s Proxy Statement dated March 23, 2023, informed the Company of his intention to retire in April 2024.
On February 24, 2023, Dirk Kloosterboer, a member of the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) since 2014, notified the Board that he plans to retire from the Board effective at the Company’s 2023 Annual Meeting of Stockholders (the “2023 Annual Meeting”).
On January 24, 2023, Mary Korby, a member of the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) since 2014, notified the Board that she plans to retire from the Board effective at the Company’s 2023 Annual Meeting of Stockholders (the “2023 Annual Meeting”).
On January 26, 2023, the Board elected Larry A. Barden to the Board effective immediately.
elected Celeste A. Clark, Ph.D., to the Board effective immediately.
On July 2, 2021, Nicole M. Ringenberg (“ Ms. Ringenberg ”) informed Darling Ingredients Inc. (the “ Company ”) that she is stepping down from the Company’s Board of Directors effective July 15, 2021.
Max materiality 0.85 · Median 0.60 · Most common event earnings